India, Oct. 12 -- Stryker Corp. (SYK), a medical technology company, announced a strategic equity investment of approximately $400 million (300 million Euros), with an exclusive option to acquire the remaining equity of CMR Surgical and an exclusive U.S. commercial agency agreement for the Versius portfolio.
CMR Surgical is a medical devices company and has Versius Plus, a next-generation surgical robot. Stryker, meanwhile, offers products and services in MedSurg, Neurotechnology, and Orthopaedics.
The agreement comes amid growing adoption of robotic-assisted surgery and is intended to help healthcare providers expand their robotic surgery programs.
The Versius platform features a modular architecture designed to support use across a ran...